Limit Hydroxyzine to Reduce Cardiac Risks, EU Regulators Say Limit Hydroxyzine to Reduce Cardiac Risks, EU Regulators Say

Clinicians should prescribe the lowest effective dose for the shortest period possible to reduce the risk for potentially fatal heart arrhythmias, an EMA committee has recommended. News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Internal Medicine News Alert Source Type: news